REAP Financial Group, LLC
Source: SEC Form 13F · as of Mar 2026REAP Financial Group, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $3.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$3.2M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 3,170 | $775K |
| LLYELI LILLY & Co | 504 | $463K |
| ABBVAbbVie Inc. | 1,996 | $434K |
| MRKMerck & Co., Inc. | 2,450 | $295K |
| PMPhilip Morris International Inc | 1,390 | $230K |
| PFEPFIZER INC | 6,761 | $190K |
| GILDGILEAD SCIENCES, INC. | 1,228 | $171K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 505 | $137K |
| CAHCardinal Health Inc. | 631 | $133K |
| AMGNAMGEN INC | 266 | $94K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 184 | $82K |
| ABTABBOTT LABORATORIES | 650 | $67K |
| BMYBRISTOL MYERS SQUIBB CO | 985 | $60K |
| MCKMcKesson Corporation | 25 | $22K |
| NVONovo Nordisk A/S | 155 | $6K |
| AVIRAtea Pharmaceuticals, Inc. | 100 | $538 |
| FBRXForte Biosciences, Inc. | 3 | $78 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.